These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 29143609)

  • 1. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
    Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers.
    Reipold EI; Trianni A; Krakower D; Ongarello S; Roberts T; Easterbrook P; Denkinger C
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):702. PubMed ID: 29143612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of HCV testing approaches in low and middle income countries.
    Morgan JR; Servidone M; Easterbrook P; Linas BP
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):697. PubMed ID: 29143681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile.
    Ivanova Reipold E; Easterbrook P; Trianni A; Panneer N; Krakower D; Ongarello S; Roberts T; Miller V; Denkinger C
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):707. PubMed ID: 29143620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries.
    Easterbrook PJ;
    J Hepatol; 2016 Oct; 65(1 Suppl):S46-S66. PubMed ID: 27641988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection.
    Corcorran MA; Scott JD; Naveira M; Easterbrook P
    BMC Health Serv Res; 2023 Aug; 23(1):849. PubMed ID: 37568106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C.
    Corcorran MA; Thornton K; Struminger B; Easterbrook P; Scott JD
    BMC Health Serv Res; 2023 Aug; 23(1):824. PubMed ID: 37533025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.
    Tucker JD; Meyers K; Best J; Kaplan K; Pendse R; Fenton KA; Andrieux-Meyer I; Figueroa C; Goicochea P; Gore C; Ishizaki A; Khwairakpam G; Miller V; Mozalevskis A; Ninburg M; Ocama P; Peeling R; Walsh N; Colombo MG; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):701. PubMed ID: 29143673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions.
    Easterbrook P; Johnson C; Figueroa C; Baggaley R
    AIDS Rev; 2016; 18(1):3-14. PubMed ID: 26991825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of viral hepatitis.
    Easterbrook PJ; Roberts T; Sands A; Peeling R
    Curr Opin HIV AIDS; 2017 May; 12(3):302-314. PubMed ID: 28306597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
    Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
    Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
    Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.
    Oru E; Trickey A; Shirali R; Kanters S; Easterbrook P
    Lancet Glob Health; 2021 Apr; 9(4):e431-e445. PubMed ID: 33639097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries.
    Nayagam S; Sicuri E; Lemoine M; Easterbrook P; Conteh L; Hallett TB; Thursz M
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):692. PubMed ID: 29143675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.